Curanex Pharmaceuticals Inc (CURX) Balance Sheet
CURX balance sheet, 2025
December 31, 2025 · U.S. dollars$11.6M assets = $361,040 liabilities + $11.2M equity
Both columns are drawn to the same scale: what CURX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
CURX financial health
Descriptive bands, not a rating. Fiscal 2025.
CURX balance sheet trends, 2022–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $10,2322022 | $11.6M2025 | +942.1%/yr | |
| Total liabilities | $02022 | $361,0402025 | — | |
| Shareholders’ equity | $10,2322022 | $11.2M2025 | +931.2%/yr | |
| Cash & short-term investments | $2,4302022 | $5.0M2025 | +1,169.6%/yr | |
| Working capital | $10,2322022 | $11.1M2025 | +$11.1M | |
| Book value per share | $0.012022 | $7.922025 | +924.0%/yr | |
| Shares outstanding | 1.4M2022 | 1.4M2025 | +0.7%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
CURX assets
CURX liabilities and equity
CURX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
CURX balance sheet
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | $5.0M | $148,891 | $74,366 | $2,430 |
| Cash & equivalents | $5.0M | $148,891 | $74,366 | $2,430 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $2,987 |
| Other current assets | $6.3M | $369,044 | $0 | $4,815 |
| Total current assets | $11.2M | $517,935 | $74,366 | $10,232 |
| Property, plant & equipment (net) | $352,616 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 |
| Total assets | $11.6M | $517,935 | $74,366 | $10,232 |
| Liabilities | ||||
| Accounts payable | $2,426 | $5,000 | $0 | — |
| Short-term debt | $122,689 | — | — | — |
| Total current liabilities | $137,030 | $14,575 | $14,276 | $0 |
| Long-term debt | $0 | $0 | $0 | $0 |
| Lease obligations | $346,699 | $0 | — | — |
| Other long-term liabilities | $224,010 | $0 | $0 | $0 |
| Total liabilities | $361,040 | $14,575 | $14,276 | $0 |
| Shareholders' equity | ||||
| Common stock & paid-in capital | $2,834 | $2,400 | $60 | — |
| Retained earnings (deficit) | −$4.8M | −$622,449 | −$260,943 | −$241,745 |
| Total shareholders' equity | $11.2M | $503,360 | $60,090 | $10,232 |
| Key figures | ||||
| Total debt | $346,699 | — | — | — |
| Net cash (debt) | $4.6M | — | — | — |
| Working capital | $11.1M | $503,360 | $60,090 | $10,232 |
| Tangible book value | $11.2M | $503,360 | $60,090 | $10,232 |
| Book value per share | $7.92 | $0.36 | $0.04 | $0.01 |
| Shares outstanding | 1.4M | 1.4M | 1.4M | 1.4M |
| Current ratio | 81.93 | 35.54 | 5.21 | — |
| Quick ratio | 36.29 | 10.22 | 5.21 | — |
| Debt / equity | 0.03 | — | — | — |
| Equity / assets | 96.9% | 97.2% | 80.8% | 100.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & short-term investments | $2.9M | $4.0M | $5.0M | $5.8M | $108,862 | $198,943 | $148,891 | $244,320 | $374,261 |
| Cash & equivalents | $2.9M | $4.0M | $5.0M | $5.8M | $108,862 | $198,943 | $148,891 | $244,320 | $374,261 |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $1.9M | $4.1M | $6.3M | $8.6M | $602,475 | $497,129 | $369,044 | $327,127 | $292,128 |
| Total current assets | $4.8M | $8.1M | $11.2M | $14.4M | $711,337 | $696,072 | $517,935 | $571,447 | $666,389 |
| Property, plant & equipment (net) | $280,939 | $317,574 | $352,616 | $60,398 | $75,837 | $90,868 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $74,676 | $49,443 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $5.1M | $8.4M | $11.6M | $14.5M | $787,174 | $786,940 | $517,935 | $646,122 | $715,832 |
| Liabilities | |||||||||
| Accounts payable | $154 | $8,404 | $2,426 | $114,489 | $269 | $126,057 | $5,000 | — | — |
| Short-term debt | $94,411 | $107,090 | $122,689 | $61,150 | $70,636 | $62,618 | — | — | — |
| Total current liabilities | $104,306 | $128,734 | $137,030 | $185,955 | $75,927 | $192,605 | $14,575 | $5,600 | $600 |
| Long-term debt | $0 | $0 | $0 | $0 | $400,000 | $200,000 | $0 | $0 | $0 |
| Lease obligations | $276,359 | $311,000 | $346,699 | $61,150 | $76,452 | $91,176 | $0 | — | — |
| Other long-term liabilities | $181,948 | $203,910 | $224,010 | $0 | $5,816 | $28,558 | $0 | $0 | $1 |
| Total liabilities | $286,254 | $332,644 | $361,040 | $185,955 | $481,743 | $421,163 | $14,575 | $5,599 | $601 |
| Shareholders' equity | |||||||||
| Common stock & paid-in capital | $2,836 | $2,836 | $2,834 | $2,834 | $2,400 | $2,400 | $2,400 | $4,000 | $4,000 |
| Retained earnings (deficit) | −$11.3M | −$8.0M | −$4.8M | −$1.8M | −$820,378 | −$760,032 | −$622,449 | −$485,286 | −$385,345 |
| Total shareholders' equity | $4.8M | $8.1M | $11.2M | $14.3M | $305,431 | $365,777 | $503,360 | $640,523 | $715,231 |
| Key figures | |||||||||
| Total debt | $276,359 | $311,000 | $346,699 | $61,150 | $476,452 | $291,176 | — | — | — |
| Net cash (debt) | $2.7M | $3.7M | $4.6M | $5.8M | −$367,590 | −$92,233 | — | — | — |
| Working capital | $4.7M | $8.0M | $11.1M | $14.2M | $635,410 | $503,467 | $503,360 | $565,847 | $665,789 |
| Tangible book value | $4.8M | $8.1M | $11.2M | $14.3M | $305,431 | $365,777 | $503,360 | $565,847 | $665,788 |
| Book value per share | $3.38 | $5.70 | $7.92 | $10.09 | $0.22 | $0.26 | $0.36 | $0.46 | $0.52 |
| Shares outstanding | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M | 1.4M |
| Current ratio | 45.95 | 62.87 | 81.93 | 77.53 | 9.37 | 3.61 | 35.54 | 102.04 | 1,110.65 |
| Quick ratio | 28.17 | 31.22 | 36.29 | 31.35 | 1.43 | 1.03 | 10.22 | 43.63 | 623.77 |
| Debt / equity | 0.06 | 0.04 | 0.03 | 0.00 | 1.56 | 0.80 | — | — | — |
| Equity / assets | 94.4% | 96.0% | 96.9% | 98.7% | 38.8% | 46.5% | 97.2% | 99.1% | 99.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 30, 2026); data from EODHD.
CURX financial position
At the end of fiscal 2025 (December 31, 2025), Curanex Pharmaceuticals had total assets of $11.6 million (up 2,135.8% from a year earlier), total liabilities of $0.4 million and shareholders' equity of $11.2 million. It held $5.0 million in cash and short-term investments against $0.3 million of debt, a net cash position of $4.6 million. Its current ratio was 81.93. In the latest quarter (ended June 30, 2026) total assets were $5.1 million and equity $4.8 million.
Related: CURX income statement, CURX cash flow statement, CURX key metrics. See the CURX stock overview for the latest quote and news.
CURX balance sheet FAQ
What are Curanex Pharmaceuticals's total assets?
Curanex Pharmaceuticals reported total assets of $11.6 million at the end of fiscal 2025 (December 31, 2025), compared with $0.5 million a year earlier.
How much debt does Curanex Pharmaceuticals have?
Curanex Pharmaceuticals had $0.3 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.03.
How much cash does Curanex Pharmaceuticals have?
Curanex Pharmaceuticals held $5.0 million in cash and short-term investments at the end of fiscal 2025; with $0.3 million of debt that is net cash of $4.6 million.
What is Curanex Pharmaceuticals's book value?
Curanex Pharmaceuticals's shareholders' equity (book value) was $11.2 million at the end of fiscal 2025, or $7.92 per share.
What is Curanex Pharmaceuticals's current ratio?
Curanex Pharmaceuticals had current assets of $11.2 million and current liabilities of $0.1 million, a current ratio of 81.93 (it can cover its short-term obligations).